Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam.
D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000517:prevention & control*; D008297:Male; D008706:Methemoglobin / Q000378:metabolism; D010963:Plasmodium falciparum / Q000187:drug effects*; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014481:United States; D014744:Vietnam
D000962:Antimalarials; D013449:Sulfonamides; D002738:Chloroquine; D003622:Dapsone; D008706:Methemoglobin; D011803:Quinine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine